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Varicella (chickenpox) infection during pregnancy can
lead to serious maternal, intrauterine, or perinatal infec-
tions, depending on the time of exposure [1]. Varicella
infection during the third trimester is associated with
severe maternal morbidity due to increased incidences
of pneumonia and multiorgan involvement, including
hepatitis, myocarditis, encephalitis, and pancreatitis [1].
However varicella-associated Guillain-Barré syndrome
in the third trimester of pregnancy has not previously
been reported. Guillain-Barré syndrome in the third
trimester is associated with increased maternal risks of
respiratory complications and premature delivery [2].
A 32-year-old primigravida presented with a 10-day
history of acute onset, progressive weakness of all four
limbs during the third trimester. At the time of presen-
tation to the emergency services, she was unable to bear
weight on her legs and had upper limb involvement in
the form of difficulty raising her arms above the shoul-
der or combing her hair. She had developed a mild fever
and a generalized vesicular rash all over the body, sug-
gestive of varicella zoster virus (VZV) infection (Figure),
2 weeks prior to the onset of limb weakness. Abdominal
examination showed a pregnancy of 32 weeks of gesta-
tion with normal fetal movements and cardiac activity.
Sonographic examination revealed a single viable fetus
corresponding to the predicted gestational age, with no
congenital malformation. Nervous system examination
of the patient confirmed reduced power of grade 3/5 in
the upper limbs, and grade 2/5 in the lower limbs. There
was generalized hypotonia and areflexia with bilateral
flexor plantar response. The cranial nerves were spared
and there was no sensory impairment or bladder or
bowel involvement. During her hospital stay, the
patient’s weakness progressed over the next 24 hours
and she developed bilateral facial weakness; however, her
respiratory effort remained good. Electrophysiological
studies revealed evidence of demyelinating polyradicu-
loneuropathy in the form of prolonged distal latencies
of compound muscle action potentials, reduced con-
duction velocities and absent “F” waves. A diagnosis
of Guillain-Barré syndrome was therefore confirmed.
Cerebrospinal fluid (CSF) contained 5 cells/μL; proteins,
72 mg/dL (normal, 15–45 mg/dL); and sugar, 64 mg/dL
(normal). Serum VZV complement fixation antibody
titer was 1:128; however, polymerase chain reaction of
VZV in the CSF was not performed. The patient was
treated with intravenous immunoglobulin (IVIg) therapy
at dose of 2 g/kg (a total of 100 g) in divided doses,
administered over 5 days. Her neurologic condition
stabilized over the next few weeks, with improvement in
muscle power. The patient was kept under observation
in the hospital and repeated neurologic examinations
were performed, with regular monitoring of respiratory
functions. Her pregnancy was supervised, with regular
clinical and ultrasound examinations to monitor fetal
growth and maturity. She went into labor at 37 weeks
of gestation and delivered a healthy male baby weighing
2.7 kg, with a normal Apgar score of 10. Outlet forceps
with right mediolateral episiotomy were used to reduce
the duration of the second stage of labor, because of
Figure. Varicella skin lesions at different stages. Generalized
maculopapular rash, vesicles on erythematous base and crusts.
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maternal exhaustion. The serology of the neonate was
negative for congenital varicella infection. Following
delivery, the patient continued to have steady improve-
ment in power, with grade 4/5 in both upper and lower
limbs at 1-month follow-up.
Guillain-Barré syndrome, or acute inflammatory
demyelinating polyradiculoneuropathy, is an acute
monophasic demyelinating neuropathy with symmetri-
cal muscle weakness, areflexia, and ascending paralysis.
Relapse during successive pregnancies has been reported
[2]. Although no apparent difference in incidence of
Guillain-Barré syndrome between pregnancy and the
normal population has been reported, only 50 cases
have been reported during pregnancy, including cases in
all trimesters of pregnancy, as well as the postpartum
period [3]. Guillain-Barré syndrome is generally believed
to carry a high maternal risk; as many as 34.5% of
women suffering from Guillain-Barré syndrome during
pregnancy have been reported to require ventilatory
support with maternal mortality exceeding 10% [4].
Patients with Guillain-Barré syndrome commonly
have a history of upper respiratory tract infection (40%)
or gastroenteritis (20%) within 4 weeks prior to the
onset of the disease [5,6]. Among the known infectious
agents, Campylobacter jejuni, cytomegalovirus, Epstein-
Barr virus and Mycoplasma pneumoniae have been recently
recognized as the most common pathogens associated
with Guillain-Barré syndrome in the non-pregnant pop-
ulation. Guillain-Barré syndrome following varicella
infection is rare, comprising only 1% of antecedent
infections [6]. Autoantibodies and immune complex-
mediated damage to the peripheral nerves is proposed
as the underlying cause of Guillain-Barré syndrome 
following infections, and both anti-GM1 IgM and anti-
GD-1 IgM antibodies have been reported in Guillain-
Barré syndrome associated with VZV [7]. Both plasma
exchange and IVIg therapy have been shown to shorten
the duration of artificial ventilation and the period of
inability to walk, thereby reducing the morbidity and
mortality in pregnant women [8]. However, IVIg ther-
apy is preferred because it is associated with fewer side
effects. IVIg therapy in the index case led to significant
neurologic improvements and subsequent uneventful
delivery.
To conclude, despite advances in the treatment of
Guillain-Barré syndrome and in standards of intensive
care, its early diagnosis and active treatment with IVIg or
plasmapheresis, together with the prevention of com-
plications, are the keys to successful management of
pregnant women with Guillain-Barré syndrome.
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